A fusion protein of IL-15-IL-15Ra and anti-FAP caused superior targeted anti-tumor killing ability, providing a rationale for the development of antibody-IL-15-IL-15Ra fusion proteins for cancer immunotherapy in the future [36]. This evidence concerns the gene IL15 and neoplasm.